title: Increased release of immunoreactive CCK-8 by electroacupuncture and enhancement of electroacupuncture analgesia by CCK-B antagonist in rat spinal cord.
abstract: Cholecystokinin octapeptide (CCK-8) in CNS has been shown to function as a neuropeptide with potent anti-opioid activity. It hinders opioid analgesia and facilitates opioid tolerance. The present study showed that electroacupuncture (EA) stimulation produced a marked increase of the CCK-8 immunoreactivity (ir) in the perfusate of the rat spinal cord. The increase of CCK-8-ir was most marked in response to EA of 100 Hz and 15 Hz, and less marked in response to EA of 2 Hz. Since CCK-8 has been shown to possess potent anti-opioid activity at the spinal level, blockade of the spinal CCK effect would be expected to potentiate EA-induced analgesia which is known to be opioid-mediated. Intrathecal (i.t.) administration of CCK-B antagonist L-365,260 per se did not affect tail flick latency (TFL) to any significant extent, yet it potentiated EA induced analgesia in a dose- and frequency-dependent manner. The potentiation was most marked at a dose range of 2.5-5.0 ng (i.t.) and at a frequency rank order of 100 Hz > 15 Hz > 2 Hz. The results suggest that an increased release of CCK-8 following EA may limit the effect of opioid peptides, and that the CCK-B receptor mediates the anti-opioid effect of CCK-8 in rat spinal cord.
authors: Neuroscience Research Center, Beijing Medical University, People's Republic of China.
authors: Y
authors: Y
authors: Zhou
authors: Y H
authors: YH
authors: Sun
authors: J M
authors: JM
authors: Shen
authors: J S
authors: JS
authors: Han
mesh_terms: D015667:Acupuncture Analgesia / Q000379:methods*; D000818:Animals; D001570:Benzodiazepinones / Q000008:administration & dosage; D015671:Electroacupuncture; D007278:Injections, Spinal; D008297:Male; D009479:Neuropeptides / Q000378:metabolism*; D010671:Phenylurea Compounds; D011863:Radioimmunoassay; D051381:Rats; D017208:Rats, Wistar; D011949:Receptors, Cholecystokinin / Q000037:antagonists & inhibitors; D012844:Sincalide / Q000378:metabolism*; D013116:Spinal Cord / Q000378:metabolism*
chemical_list: D001570:Benzodiazepinones; D009479:Neuropeptides; D010671:Phenylurea Compounds; D011949:Receptors, Cholecystokinin; C058121:L 365260; D012844:Sincalide